Physician profile
Prasanna V Kumar
NPI 1437280971
$3,258.80
in general payments reported to CMS, 2019-2025
22 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $139 · 2021: $221 · 2022: $701 · 2023: $1,087 · 2024: $491 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,729 · Consulting Fee: $15.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,728.51 |
| Consulting Fee | $15.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $434.95 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $403.33 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $356.24 | 2021-2024 | Verquvo, Bridion |
| Lexicon Pharmaceuticals, INC. | $249.43 | 2023-2024 | Inpefa |
| Amgen INC. | $213.77 | 2022-2024 | Repatha |
| Baxter Healthcare | $196.11 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Janssen Pharmaceuticals, INC | $180.96 | 2019-2024 | Xarelto |
| Abbott Laboratories | $179.93 | 2019-2023 | Jot Dx |
| Boston Scientific Corporation | $177.02 | 2019-2025 | Avvigo Guidance System |
| Pfizer INC. | $166.14 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $152.92 | 2019-2023 | Farxiga, Brilinta |
| Bardy Diagnostics, INC. | $129.75 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.24 | 2019-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $98.16 | 2022-2024 | Camzyos, Eliquis |
| Regeneron Healthcare Solutions, INC. | $34.39 | 2022-2023 | Evkeeza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $32.63 | 2022 | |
| Medtronic Vascular, INC. | $29.99 | 2019-2020 | |
| Daiichi Sankyo INC. | $22.30 | 2024 | Injectafer |
| Medtronic, INC. | $21.22 | 2022 | |
| Scpharmaceuticals INC. | $21.09 | 2023 | |
| Philips North America LLC | $15.41 | 2022 | |
| Biotronik INC. | $13.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prasanna Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.